Delivery Order SPE2DB20D1100-SPE2DB24FZ48D
Award Date 12/28/23
Potential Completion Date 12/29/23
Potential Value $3.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RESTASIS 0.05% eye emulsion. The $102,045.12 contract has a completion date of December 2, 2021 and does not use a set-aside designation. Amerisourcebergen Drug Corp, as a prime contractor, has a history of providing pharmaceuticals, medical supplies, and distribution services to support DLA programs....
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of RESTASIS 0.05% eye emulsion 60s. The $4,021.92 contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply RESTASIS 0.05% eye emulsion. The $7,490.14 order is for delivery by January 24, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that provides pharmaceutical products and services to the Department of Defense. This order is part of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RESTASIS 0.05% Eye Emulsion. The order, valued at $22,573.33, has a completion date of February 9, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,384.77 order is for the provision of RESTASIS 0.05% eye emulsion, a specialty pharmaceutical product, with a completion date of February 28, 2024. This delivery order falls under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA,...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Restasis 0.05% eye emulsion. The $3,827.40 contract has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA with a performance period through December...
- The Department of Defense has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RESTASIS 0.05% eye emulsion, a specialty pharmaceutical product, through January 29, 2024. The $3,750.29 award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which manages contracting for medical supplies and pharmaceuticals for the U.S. military. This delivery order is part of a larger indefinite delivery...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $46,862.84 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. This contract is for the supply of RESTASIS 0.05% eye emulsion, a specialty pharmaceutical product. The contract has an ultimate completion date of June 9, 2022. AmerisourceBergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RESTASIS 0.05% eye emulsion in 60-count packages. The $28,038.28 order was placed against Amerisourcebergen's existing contract to supply pharmaceuticals and medical supplies to DLA Troop Support Medical facilities. Amerisourcebergen, a leading global pharmaceutical distributor, has extensive experience supporting Department of Defense...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RESTASIS 0.05% eye emulsion 30-count packages. The $106,246.03 delivery order was awarded on November 18, 2021 with a completion date of November 19, 2021. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical...